Derrell Porter - 28 May 2025 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role: Director
Signature: /s/ Kathleen Borthwick, Attorney-in-Fact
Issuer symbol: PASG
Transactions as of: 28 May 2025
Net transactions value: $0
Form type: 4
Filing time: 30 May 2025, 19:29:26 UTC
Previous filing: 10 Jun 2024
Next filing: 05 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Porter Derrell	Director	ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA	/s/ Kathleen Borthwick, Attorney-in-Fact	30 May 2025	0001706400

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PASG	Director Stock Option (right to buy)	Award	$0	+201,857		$0.000000	201,857	28 May 2025	Common Stock	201,857	$0.3598	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.